Extensive validation of the mechanism of action of ONC201 has been conducted in CRC xenografts in mice including correlative assays and genetic studies that demonstrate engagement of the Akt/ERK/Foxo3a/TRAIL/DR5 signaling axis in tumors [1, 31]. This evidence concerns the gene FOXO3 and colorectal carcinoma.